June 30, 2025 — Vicarious Surgical (NYSE: RBOT) announced the election of Fuad Ahmad and Joseph Doherty to its board of directors, effective June 27. The company also marked the departure of longtime board member Ric Fulop.
Ahmad brings extensive financial leadership in medtech, having served as CFO of Iridex and other healthcare companies. Doherty offers deep industry experience from his roles at Olympus Surgical Technologies America and Johnson & Johnson.
Based in Waltham, Massachusetts, Vicarious continues to develop its human-like surgical robot system, Version 1.0 (V1.0), designed to enhance minimally invasive surgery. The company aims for FDA submission by early to mid-fiscal 2026 and is advancing toward clinical trials and commercialization.
CEO Adam Sachs praised the new directors’ expertise as pivotal for Vicarious’ next growth phase.
Follow MEDWIRE.AI for surgical robotics and medtech leadership updates.
